A molecular model of the human UDP-glucuronosyltransferase 1A1, its membrane orientation, and the interactions between different parts of the enzyme

Molecular Pharmacology

Volumn 77, Issue 6, 2010, Pages 931-939

  Laakkonen, Liisa ^a   Finel, Moshe ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONOSYLTRANSFERASE 1A1;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CATALYSIS; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; ENDOPLASMIC RETICULUM; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; GLUCURONIDATION; GLYCOSYLATION; HUMAN; MEMBRANE STRUCTURE; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; BILIRUBIN; GLUCURONOSYLTRANSFERASE; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN CONFORMATION; SUBSTRATE SPECIFICITY;

EID: 77952349321     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.063289     Document Type: Article

References (42)

1. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, and Lipman DJ (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389-3402. (Pubitemid 27359211)
2. Barton GJ (1993) ALSCRIPT: a tool to format multiple sequence alignments. Protein Eng 6:37-40.
3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, and Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28:235-242.
4. Bosma PJ, Seppen J, Goldhoorn B, Bakker C, Oude Elferink RP, Chowdhury JR, Chowdhury NR, and Jansen PL (1994) Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 269:17960-17964.
5. Brazier-Hicks M, Offen WA, Gershater MC, Revett TJ, Lim EK, Bowles DJ, Davies GJ, and Edwards R (2007) Characterization and engineering of the bifunctional Nand O-glucosyltransferase involved in xenobiotic metabolism in plants. Proc Natl Acad Sci USA 104:20238-20243.
6. Ceroni A, Passerini A, Vullo A, and Frasconi P (2006) DISULFIND: a disulfide bonding state and cysteine connectivity prediction server. Nucleic Acids Res 34:W177-W181.
7. Ciotti M, Cho JW, George J, and Owens IS (1998) Required buried α-helical structure in the bilirubin UDP-glucuronosyltransferase UGT1A1 contains a nonreplaceable phenylalanine. Biochemistry 37:11018-11025.
8. Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, Wang X, Murray LW, Arendall WB 3rd, Snoeyink J, Richardson JS, et al. (2007) MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35:W375-W383.
9. Finel M and Kurkela M (2008) The UDP-glucuronosyltransferases as oligomeric enzymes. Curr Drug Metab 9:70-76.
10. Fujiwara R, Nakajima M, Yamamoto T, Nagao H, and Yokoi T (2009a) In silico and in vitro approaches to elucidate the thermal stability of human UDP-glucuronosyltransferase (UGT) 1A9. Drug Metab Pharmacokinet 24:235-244.
11. Fujiwara R, Nakajima M, Yamanaka H, and Yokoi T (2009b) Key amino acid residues responsible for the differences in substrate specificity of human UDP glucuronosyltransferase (UGT)1A9 and UGT1A8. Drug Metab Dispos 37:41-46.
12. Ghosh SS, Lu Y, Lee SW, Wang X, Guha C, Roy-Chowdhury J, and Roy-Chowdhury N (2005) Role of cysteine residues in the function of human UDP glucuronosyl-transferase isoform 1A1 (UGT1A1). Biochem J 392:685-692.
13. Hans J, Brandt W, and Vogt T (2004) Site-directed mutagenesis and protein 3D-homology modelling suggest a catalytic mechanism for UDP-glucose-dependent betanidin 5-O-glucosyltransferase from Dorotheanthus bellidiformis. Plant J 39:319-333.
14. Holm L, Kääriäinen S, Rosenström P, and Schenkel A (2008) Searching protein structure databases with DaliLite v.3. Bioinformatics 24:2780-2781. (Pubitemid 352722625)
15. Humphrey W, Dalke A, and Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14:27-28, 33-38.
16. Kerdpin O, Mackenzie PI, Bowalgaha K, Finel M, and Miners JO (2009) Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10. Drug Metab Dispos 37:1948-1955.
17. Kurkela M, Hirvonen J, Kostiainen R, and Finel M (2004a) The interactions between the N-terminal and C-terminal domains of the human UDP- glucuronosyltransferases are partly isoform-specific, and may involve both monomers. Biochem Pharmacol 68:2443-2450. (Pubitemid 39535117)
18. Kurkela M, Mörsky S, Hirvonen J, Kostiainen R, and Finel M (2004b) An active and water-soluble truncation mutant of the human UDP- glucuronosyltransferase 1A9. Mol Pharmacol 65:826-831. (Pubitemid 38420487)
19. Lairson LL, Henrissat B, Davies GJ, and Withers SG (2008) Glycosyltransferases: structures, functions, and mechanisms. Annu Rev Biochem 77:521-555.
20. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23:2947-2948.
21. Lewis BC, Mackenzie PI, Elliot DJ, Burchell B, Bhasker CR, and Miners JO (2007) Amino terminal domains of human UDP-glucuronosyltransferases (UGT) 2B7 and 2B15 associated with substrate selectivity and autoactivation. Biochem Pharmacol 73:1463-1473.
22. Li C and Wu Q (2007) Adaptive evolution of multiple-variable exons and structural diversity of drug-metabolizing enzymes. BMC Evol Biol 7:69.
23. Li D, Fournel-Gigleux S, Barré L, Mulliert G, Netter P, Magdalou J, and Ouzzine M (2007) Identification of aspartic acid and histidine residues mediating the reaction mechanism and the substrate specificity of the human UDP-glucuronosyltransferases 1A. J Biol Chem 282:36514-36524.
24. Locuson CW and Tracy TS (2007) Comparative modelling of the human UDP-glucuronosyltransferases: insights into structure and mechanism. Xenobiotica 37:155-168. (Pubitemid 46269618)
25. Luukkanen L, Taskinen J, Kurkela M, Kostiainen R, Hirvonen J, and Finel M (2005) Kinetic characterization of the 1A subfamily of recombinant human UDP-glucuronosyltransferases. Drug Metab Dispos 33:1017-1026. (Pubitemid 41002784)
26. Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners JO, Owens IS, and Nebert DW (2005) Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:677-685.
27. Meech R, Yogalingam G, and Mackenzie PI (1996) Mutational analysis of the carboxyterminal region of UDP-glucuronosyltransferase 2B1. DNA Cell Biol 15:489-494.
28. Miley MJ, Zielinska AK, Keenan JE, Bratton SM, Radominska-Pandya A, and Redinbo MR (2007) Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7. J Mol Biol 369:498-511.
29. Nishiyama T, Fujishima M, Masuda Y, Izawa T, Ohnuma T, Ogura K, and Hiratsuka A (2008) Amino acid positions 69-132 of UGT1A9 are involved in the C-glucuronidation of phenylbutazone. Arch Biochem Biophys 478:75-80.
30. Nogales D and Lightner DA (1995) On the structure of bilirubin in solution. 13C[1H] heteronuclear Overhauser effect NMR analyses in aqueous buffer and organic solvents. J Biol Chem 270:73-77.
31. Noguchi A, Horikawa M, Fukui Y, Fukuchi-Mizutani M, Iuchi-Okada A, Ishiguro M, Kiso Y, Nakayama T, and Ono E (2009) Local differentiation of sugar donor specificity of flavonoid glycosyltransferase in Lamiales. Plant Cell 21:1556-1572.
32. Osmani SA, Bak S, Imberty A, Olsen CE, and Møller BL (2008) Catalytic key amino acids and UDP-sugar donor specificity of a plant glucuronosyltransferase, UGT94B1: molecular modeling substantiated by site-specific mutagenesis and biochemical analyses. Plant Physiol 148:1295-1308.
33. Ouzzine M, Magdalou J, Burchell B, and Fournel-Gigleux S (1999) An internal signal sequence mediates the targeting and retention of the human UDP-glucuronosyltransferase 1A6 to the endoplasmic reticulum. J Biol Chem 274:31401-31409.
34. Patana AS, Kurkela M, Finel M, and Goldman A (2008) Mutation analysis in UGT1A9 suggests a relationship between substrate and catalytic residues in UDP-glucuronosyltransferases. Protein Eng Des Sel 21:537-543.
35. Radominska-Pandya A, Bratton SM, Redinbo MR, and Miley MJ (2010) The crystal structure of human UDP-glucuronosyltransferase 2B7 C-terminal end is the first mammalian UGT target to be revealed: the significance for human UGTs from both the 1A and 2B families. Drug Metab Rev 42:128-139.
36. Rost B, Yachdav G, and Liu J (2004) The PredictProtein server. Nucleic Acids Res 32:W321-W326.
37. Sali A and Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779-815.
38. Seppen J, Bosma PJ, Goldhoorn BG, Bakker CT, Chowdhury JR, Chowdhury NR, Jansen PL, and Oude Elferink RP (1994) Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate- glucuronosyltransferase. J Clin Invest 94:2385-2391.
39. Stewart JJ (2007) Optimization of parameters for semiempirical methods V: modification of NDDO approximations and application to 70 elements. J Mol Model 13:1173-1213.
40. Thorsøe KS, Bak S, Olsen CE, Imberty A, Breton C, and Lindberg Møller B (2005) Determination of catalytic key amino acids and UDP sugar donor specificity of the cyanohydrin glycosyltransferase UGT85B1 from Sorghum bicolor. Molecular modeling substantiated by site-specific mutagenesis and biochemical analyses. Plant Physiol 139:664-673.
41. Unligil UM and Rini JM (2000) Glycosyltransferase structure and mechanism. Curr Opin Struct Biol 10:510-517.
42. White SH (2009) Biophysical dissection of membrane proteins. Nature 459:344-346.